EMILI HALEY: Open Payments
NPI 1801429410 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 49 payments from 12 companies in 2025. Trend: 2023 $785 · 2024 $348 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $172 |
| ABBVIE INC. | 15 | $160 |
| Neurocrine BioSciences, Inc. | 3 | $80 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $58 |
| Alkermes, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: TRINTELLIX, VRAYLAR, REXULTI, INGREZZA, Auvelity, Jornay PM, ARISTADA, UZEDY.
Industry payments across TN — which companies pay providers there.
